Pathology is the study of the causes and effects of diseases in living organisms.
病理学是研究生物体疾病原因和影响的学科。
The pathologist examined the biopsy sample under a microscope to identify any signs of cancer.
病理学家在显微镜下检查活检样本，以寻找癌症迹象。
She pursued a career in
pathology after completing her medical degree.
她获得医学学位后选择了病理学作为职业发展道路。
A thorough autopsy was conducted by the forensic pathologist to determine the cause of death.
法医病理学家进行了详尽的尸检，以确定死因。
The study of neuro
pathology helps us understand the changes that occur in the brain in neurological disorders.
神经病理学的研究有助于我们理解神经紊乱时大脑的变化。
The histopathological examination revealed inflammation in the lung tissue.
组织病理学检查显示肺部组织有炎症。
Pathologists work closely with oncologists to interpret biopsy results for cancer treatment planning.
病理学家与肿瘤科医生紧密合作，解读活检结果以制定癌症治疗方案。
Post-mortem
pathology confirmed the victim's cause of death as a heart attack.
尸检病理学证实受害者死因是心脏病发作。
The patient's biopsy showed signs of advanced stage
pathology, indicating a poor prognosis.
患者的活检结果显示病变已进入晚期，预后不佳。
Pathologists use various stains and techniques to visualize different cellular structures and processes in diseased tissues.
病理学家使用各种染料和方法来观察病变组织中的不同细胞结构和过程。
For instance, the company has developed digital management tools for early detection and intervention of tumor patients, as well as artificial intelligence-based digital pathology and imaging devices that can help doctors to make diagnosis and predict recovery.
例如，该公司开发了用于肿瘤患者早期检测和干预的数字管理工具，以及基于人工智能的数字病理和成像设备，可以帮助医生进行诊断和预测康复。
The firm's existing Asian portfolio of healthcare and consumer companies include Novotech, One Health Asia, Pathology Asia, Greencross, CrownX, Sai Life, Kangji and Dingdang Health.
该公司现有的亚洲医疗保健和消费公司组合包括Novotech、One Health Asia、Pathology Asia、Greencross、CrownX、Sai Life、Kangji和叮当健康。
TPG's existing portfolio of fast-growing healthcare and consumer companies include Novotech, Greencross, Made and Funlab in Australia, and One Health Asia, Pathology Asia, Sai Life and Kangji in Asia.
TPG现有的快速增长的医疗保健和消费公司组合包括澳大利亚的Novotech、Greencross、Made和Funlab，以及亚洲的One Health Asia、Pathology Asia、Sai Life和Kangji。
According to the China Medical Devices Industry Association, Olympus' endoscopy products are used in over 90 percent of Chinese hospitals rated at a 3A grade — the highest of China's three-tier grading system for public hospitals — while its pathology microscopes account for about 30 percent of the country's market share.
A supporting tumor gene detection kit for the system has also been successfully developed, which can be adapted to many types of samples from tissues to body fluids, including glioma, lung, urothelial, breast and thyroid cancers, covering the fields of early screening, molecular pathology diagnosis and medication guidance, the company said.
"According to the China Medical Devices Industry Association, Olympus' endoscopy products are used in over 90 percent of Chinese hospitals with 3A grade, the highest of China's three-tier grading system for public hospitals, while its pathology microscopes account for about 30 percent of market share.
Olympus said its endoscopy products are used in over 90 percent of Chinese hospitals with 3A grade, the highest of China's three-tier grading system for public hospitals, while its pathology microscopes account for about 30 percent of market share.
Merck is also partnering with different AI players in different areas from digital pathology to drug research.
The committee is led by Zhong Nanshan, a renowned respiratory expert and academic at the Chinese Academy of Engineering, and consists of three other leading academics and 23 domestic and overseas experts in the areas of medical testing, pathology and clinical trials.
"The academic committee will be dedicated to advanced technology research and the development of testing, pathology and clinical trial areas," said Liang Yaoming, CEO of Guangzhou KingMed Diagnostics.
Digital pathological diagnosis, or digital pathology, adopts intelligent algorithms to increase efficiency and accuracy, shorten the period of report generation and resolve hospital staff shortages.
According to the 2022 China White Paper on Digital Pathology issued by the Shanghai Digital Medicine Innovation Center and Beijing-based think tank Equal-Ocean, 80 percent of the surveyed pathologists think that digital pathology increases efficiency by 50 percent.
The white paper stated that 40 percent of the surveyed hospitals are building or have built a digital pathology system.
The system requires an accumulated investment of some 10 million yuan to build a complete digital pathology system and the construction period can be long, experts said.
In 2022, about 23 percent of remote clinical consultations were reported to have used digital pathology, the white paper said.
The nation is undergoing a transformation from traditional pathological diagnosis to digital pathology.
For hospitals that have already established a digital pathology system, the application scenario and utilization rate has been increasing and the penetration rate of digital pathology is expected to further rise, said the white paper.
Most of the surveyed doctors praised the country's digital pathology system, stating that it greatly enhances the efficiency and accuracy of pathological diagnosis, optimizes the learning curve and shortens training periods, it said.
"With the development of digital technologies, digital pathology will become mainstream in the industry.
Products such as digital pathology image browsers and AI-enabled diagnosis-assistance systems are expected to be applied widely," said Zhang Jing, a medical device expert at VBData.
"Seeing opportunity in the blue ocean, several domestic startup companies are tapping into AI-enabled digital pathology products," Zhang said.
Guangzhou, Guangdong province-based med-tech company DM Intelligence has been focusing on digital pathology for years and is mulling a new round of investment.
"Digital pathology is deeply rooted in the country's healthcare system.
The digital pathology system has become an indispensable tool for hospitals, third-party test centers, centers for disease control and prevention, and scientific research institutions," said Fan Yujun, founder of Jinan Danjier, a domestic enterprise of digital pathology.
In 2010, Fan introduced Hungarian company 3DHISTECH Ltd — the world's first self-developed digital pathology brand — to China.
During this period, China's digital pathology sector has seen leaps in development.
"A universal platform to integrate medical big data is needed to boost the optimization of the AI-enabled digital pathology system.
For instance, AI-assisted medical imaging systems were used in many Chinese hospitals amid the COVID-19 pandemic to help quickly classify pneumonia caused by the virus according to its severity, precisely calculate burden on the lungs and provide 4D dynamic pathology comparisons.
例如，在COVID-19疫情期间，许多中国医院使用了AI辅助的医学影像系统，以快速对病毒所致肺炎进行严重程度分类，精确计算肺部负担，并提供4D动态病理对比。
For instance, AI-assisted medical imaging systems were used in many Chinese hospitals amid the COVID-19 pandemic to help quickly classify the pneumonia caused by the virus according to its severity, precisely calculate the burden on the lungs and provide 4D dynamic pathology comparisons－4D adds the aspect of motion to 3D imaging.
例如，在COVID-19疫情期间，许多中国医院采用了AI辅助的医学影像系统，以快速对病毒所致肺炎进行严重程度分类，精确计算肺部负担，并提供4D动态病理对比。其中，4D是在3D成像基础上增加了运动这一维度。
The two solutions are part of applications for SenseTime's SenseCare® Smart Health Platform – an AI-powered platform that offers an array of healthcare applications for over 13 organs and body parts, covering the chest, cardiovascular system, the liver, pathology, orthopedics and radiotherapy.
The platform can assist doctors throughout the clinical process, from diagnosis and 3D surgery planning to rehabilitation tracking to meet the demands of various departments, including radiology, pathology, cardiology, orthopedics, surgery and radiotherapy, SenseTime said on its official website.
The recently introduced AI system can classify the pneumonia caused by the virus according to its severity, precisely calculate the burden on the lungs and provide 4D dynamic pathology comparisons.
The recently introduced AI system can classify pneumonia caused by the virus according to its severity, precisely calculate the burden on the lungs and provide 4D dynamic pathology comparisons.